Ledger entry · candidate
Semaglutide → Blood glucose increased — Audit-grade candidate (scan)
Drug: semaglutide · AE: Blood glucose increased
Discovered via single-drug scan of semaglutide. PRR = 6.68 (95% CI 6.37–7.01), n = 1589 cases. Pre-reg locked at submission time.
Disproportionality
- PRR: 6.6800116684051405
(95% CI 6.37–7.01)
- Yates χ2: 7673.340555812696
- Cases (case-drug + AE): n = 1589
- Verdict:
PASSES_ALL_GATES — PRR=6.68 (95% CI 6.37–7.01), n=1589 cases; flagged for clinical expert review, NOT for external escalation without manual verification
Top reactions in cohort
| MedDRA PT | n |
|---|
| No reactions surfaced in cohort. |
Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.